Addressing significant inequity

Area of Science:

• Health equity research
• Biostatistics
• Clinical trial analysis

Background:

• Health research equity necessitates comparable explanatory power across sub-groups, ideally with similar sample sizes.
• Unequal sub-group sample sizes are common and can lead to misinterpretations, potentially exacerbating health inequities.
• Misinterpreting sub-group data can result in false conclusions about treatment effects, undermining research validity.

Purpose of the Study:

• To guide researchers, reviewers, and editors in analyzing and interpreting health research sub-group data.
• To highlight common pitfalls associated with small sub-group sample sizes.
• To propose best practices for presenting sub-group analysis results.

Main Methods:

• Review of common pitfalls in sub-group data analysis.
• Provision of potential considerations for researchers and editors.
• Illustrative examples of misinterpretation risks.

Main Results:

• Small sub-group sizes increase the risk of drawing erroneous conclusions.
• Misinterpretation of results can reinforce existing health inequities.
• Focusing solely on statistical significance is a common pitfall.

Conclusions:

• Researchers should prioritize presenting effect sizes and confidence intervals over statistical significance for sub-group analyses.
• Adopting these practices can mitigate risks of misinterpretation and promote more equitable research outcomes.
• Careful analysis and interpretation of sub-group data are crucial for valid and equitable health research.